Hyperactive PI3K/Akt signaling confers resistance to oxidative stress and ferroptosis in cancer cells,32 Interestingly, SELENOI knockdown reduced phosphorylated Akt (p‐Akt) levels at ser473 without affecting total Akt in TUOS3 and OVISE cells (Figure 6P). The gene discussed is AKT1; the disease is cancer.